′ capping is a tightly regulated step in RNA processing that is required for RNA stability, localization, and function 1, 2 . All caps, which vary in an RNA-and organism-dependent manner, feature one or more methyl groups added by a SAM-dependent methyltransferase (MTase; Fig. 1a) . A unique monomethyl-γ -phosphate 5′ cap (mpppG) 3 (Fig. 1b) has been identified in a small subset of RNA polymerase III transcripts, i.e., human 7SK long noncoding RNA and U6 spliceosomal RNA; rodent B2 short interspersed element RNA; and plant U3 small nucleolar RNA [3] [4] [5] . 7SK and U6 associate with the methylphosphate capping enzyme MePCE (also called BCDIN3 in mammals and Bin3 in Drosophila) 6, 7 , but only 7SK has been conclusively shown to be capped by MePCE 6, 8 . MePCE also has a nonenzymatic function as a component of the core 7SK RNP, and knockdown significantly decreases 7SK levels in vivo 6, 9 . 7SK regulates RNA polymerase II transcription elongation in higher eukaryotes by sequestering and inactivating positive transcription elongation factor b (P-TEFb) 10, 11 . P-TEFb phosphorylates the RNA polymerase II C-terminal domain and negative transcription elongation factors, thus causing RNA polymerase II to transition from a promoter-proximal paused state to productive transcription elongation 12 . 7SK constitutively assembles with MePCE at the 5′ end and with La-related protein group 7 (Larp7) at the 3′ end [13] [14] [15] . After binding 7SK, Larp7 and MePCE interact, forming a core RNP in which MePCE is inactivated [7] [8] [9] . Hexim1/2 and P-TEFb subsequently assemble onto 7SK RNP and P-TEFb is sequestered in an inactive form 10, 11, 16, 17 . Little is known about 7SK biogenesis, and two alternative secondary structures for 7SK have been proposed 18, 19 , a 'linear 7SK model' with four stem-loops 8, 18 ( Fig. 1c) , which is supported by chemical mapping and enzymatic footprinting experiments, and a 'circular 7SK model' based on sequence conservation, with up to eight stem-loops, in which the first 10 nt at the 5′ end base-pair with nucleotides near the 3′ end 19, 20 ( Supplementary Fig. 1 ). Both RNA secondary-structure models have an identical terminal stem-loop 4 (SL4), where Larp7 binds 7, [21] [22] [23] . However, the secondary structures differ at the 5′ end, where MePCE binds and caps ( Supplementary  Fig. 1 ). For U6, the consensus motif for the determinants of capping comprises a 5′ -triphosphate, a hairpin beginning at the 5′ end, and adjacent 3′ single-stranded RNA (ssRNA) with the sequence AUAUAC
′ capping is a tightly regulated step in RNA processing that is required for RNA stability, localization, and function 1, 2 . All caps, which vary in an RNA-and organism-dependent manner, feature one or more methyl groups added by a SAM-dependent methyltransferase (MTase; Fig. 1a) . A unique monomethyl-γ -phosphate 5′ cap (mpppG) 3 ( Fig. 1b) has been identified in a small subset of RNA polymerase III transcripts, i.e., human 7SK long noncoding RNA and U6 spliceosomal RNA; rodent B2 short interspersed element RNA; and plant U3 small nucleolar RNA [3] [4] [5] . 7SK and U6 associate with the methylphosphate capping enzyme MePCE (also called BCDIN3 in mammals and Bin3 in Drosophila) 6, 7 , but only 7SK has been conclusively shown to be capped by MePCE 6, 8 . MePCE also has a nonenzymatic function as a component of the core 7SK RNP, and knockdown significantly decreases 7SK levels in vivo 6, 9 . 7SK regulates RNA polymerase II transcription elongation in higher eukaryotes by sequestering and inactivating positive transcription elongation factor b (P-TEFb) 10, 11 . P-TEFb phosphorylates the RNA polymerase II C-terminal domain and negative transcription elongation factors, thus causing RNA polymerase II to transition from a promoter-proximal paused state to productive transcription elongation 12 . 7SK constitutively assembles with MePCE at the 5′ end and with La-related protein group 7 (Larp7) at the 3′ end [13] [14] [15] . After binding 7SK, Larp7 and MePCE interact, forming a core RNP in which MePCE is inactivated [7] [8] [9] . Hexim1/2 and P-TEFb subsequently assemble onto 7SK RNP and P-TEFb is sequestered in an inactive form 10, 11, 16, 17 .
Little is known about 7SK biogenesis, and two alternative secondary structures for 7SK have been proposed 18, 19 , a 'linear 7SK model' with four stem-loops 8, 18 ( Fig. 1c) , which is supported by chemical mapping and enzymatic footprinting experiments, and a 'circular 7SK model' based on sequence conservation, with up to eight stem-loops, in which the first 10 nt at the 5′ end base-pair with nucleotides near the 3′ end 19, 20 ( Supplementary Fig. 1 ). Both RNA secondary-structure models have an identical terminal stem-loop 4 (SL4), where Larp7 binds 7, [21] [22] [23] . However, the secondary structures differ at the 5′ end, where MePCE binds and caps ( Supplementary  Fig. 1 ). For U6, the consensus motif for the determinants of capping comprises a 5′ -triphosphate, a hairpin beginning at the 5′ end, and adjacent 3′ single-stranded RNA (ssRNA) with the sequence AUAUAC 24 . In 7SK, the sequence and secondary structure at the 5′ end corresponding to the linear 7SK model are important for MePCE assembly in vivo 7 . Whether one or both of the proposed secondary structures participate in MePCE capping and/or core 7SK RNP assembly remains to be determined.
MePCE contains a C-terminal MTase domain that is highly conserved among eukaryotes and a highly variable N-terminal region of low sequence complexity 25 . The structure of the MePCE MTase domain bound to S-adenosylhomocysteine (SAH) (MePCE-SAH) was determined by the Structural Genomics Consortium (PDB 5UNA). Here, we report structures of the MePCE MTase domain crystallized in the presence of 7SK substrate RNA and either SAH or SAM. Unexpectedly, despite transfer of the methyl group from SAM to the 5′ -γ -phosphate of the 7SK substrate during crystallization, the RNA remains bound to MePCE, thereby providing a unique example of a product-bound RNA MTase structure. Together with analysis of enzyme kinetics and reactant and product binding affinities, the X-ray crystal structures of MePCE-SAH in complex with uncapped (MePCE-SAH-7SK) and capped (MePCE-SAH-me7SK) RNAs reported here reveal the mechanism of methyl transfer to a phosphate group and the determinants of 7SK recognition and retention, and define the first steps of assembly of 7SK core RNP.
analyzed the subsequently purified SL1p by using NMR spectroscopy (Fig. 1d) . A unique resonance attributed to a methyl group on SL1p ([methyl- 13 C]SL1p) was observed, with a substantial chemical-shift difference relative to [methyl- 13 C]SAM (Fig. 1d) . Highresolution electrospray ionization mass spectrometry confirmed that SL1p was fully monomethylated (meSL1p) (Supplementary Fig.  3 ). These assays were performed in the absence of divalent cations ( Fig. 1d and Supplementary Fig. 3 ), thus indicating that MePCE does not require divalent cations for catalysis.
MePCE MT was crystallized in complex with SL1p in the presence of either SAH or SAM, and structures were solved from crystals that diffracted to 2.0-Å and 2.1-Å resolution, respectively (Supplementary Fig. 4 and Supplementary Table 1 ). The crystal structure of the sample with added SAM lacked the electron density expected for the SAM methyl moiety, whereas clear additional density was observed at an RNA 5′ -γ -phosphate oxygen, a result indicating that methyl transfer occurred during crystallization ( Supplementary Fig. 4) . Thus, crystal structures of MePCE MT in complex with SAH and SL1p in uncapped (MePCE-SAH-7SK) and capped (MePCE-SAH-me7SK) forms were determined ( Supplementary Fig. 4 ). The structures are nearly identical (all-atom r.m.s. deviation 0.21 Å) and show substantial differences only at the SAH and 5′ -triphosphate ( Supplementary Figs. 4 and 5) . In both structures, MePCE MT has the expected Rossman-like fold common to RNA methyltransferases 1, 2 , with an α β α β α β α β α β α β β topology (Fig. 2a,b ) also seen in RNA-free MePCE-SAH (Fig. 2c) . Helices α 1, α 2, and α 3 lie underneath the central β -sheet (↑ 3↑ 2↑ 1↑ 4↑ 5↓ 7↑ 6), and α 4, α 5, and α 6 lie above the β -sheet. Noncanonical helices α 5′ and α 6′ are located adjacent to α 5 and α 6, respectively, at the β -sheet edge (Fig. 2b,c) . In MePCE-SAH-me7SK (Fig. 2b) and MePCE-SAH-7SK ( Supplementary  Fig. 4a ), MePCE MT has two additional helices, α 0 and α 7, located in the structure between α 3 and α 5′ . SAH and the RNA 5′ -triphosphate are buried in the active site (Fig. 2b,d) . Notably, no divalent or trivalent cations are observed in the active site, even for crystals soaked with Mg 2+ or Sm 3+ (Methods). SL1p forms a 10-bp hairpin with an asymmetric (1-3) internal loop separating the bottom 3 bp and the top 7 bp, and a UUCG tetraloop; eight single-stranded nucleotides stack on one another below the terminal base pair (Figs. 1c and 2b and Supplementary Fig. 4 ). The internal loop, which is outside of the MePCE MT -binding site, has crystal contacts with nucleotides G113-A116 from another molecule in the asymmetric unit, which form non-native interactions (Supplementary Fig. 6 ).
A comparison of MePCE-SAH-me7SK (Fig. 2b) and MePCE-SAH (PDB 5UNA; Fig. 2c ) highlights the conformational changes in MePCE MT that occur after RNA binding. The structures of MePCE-SAH in the absence and presence of SL1p are globally similar (allatom r.m.s. deviation of 0.29 Å), but there are major differences around the active site and RNA-protein interface (Fig. 2e,f) . In the absence of RNA, the N terminus (residues 418-431) and C-terminal β 6-β 7 loop (residues 665-676) are partially disordered (Fig. 2c,f) , whereas in the presence of meSL1p, a helix α 0 forms near the N terminus, loop residues that connect to α 1 become ordered, and the β 6-β 7 loop adopts an ordered structure with a short helix α 7 in the middle (Fig. 2b,e) . Together with helices α 5′ and α 6′ -whose conformation does not change significantly when RNA binds, except for the Lys625 and Arg626 side chains-these elements form a tunnel that encloses the RNA triphosphate (hereafter called the triphosphate-binding tunnel) and consequently position it near the cofactor in the active site (Fig. 2d,g,h) . These new structured elements are stabilized by hydrogen bonds and stacking interactions to both RNA substrate and one another, and sequester SAH in the cofactor-binding pocket with only its sulfur group exposed to the γ -phosphate in the tunnel (Fig. 2d,g,h) . In contrast, in the absence of RNA, the SAH homocysteine is solvent accessible (Fig. 2i) . In summary, binding to SL1p induces conformational changes in MePCE MT that enclose SAH in the active site.
Extensive interaction network between MePCE MT and 7SK. In MePCE-SAH-me7SK, there is an extensive interaction network involving a highly basic surface on MePCE and the SL1p 5′ -triphosphate, two terminal base pairs, and the following six ssRNA nucleotides (Figs. 2b and 3 and Supplementary Fig. 4 ). G1 and G2 in the first 2 bp are recognized by MePCE MT helices α 5′ , α 6′ , and α 7; G1-C108 and the first two ssRNA nucleotides straddle helix α 0; and the following four ssRNA nucleotides interact primarily with helix α 3 (Figs. 2b and 3a) . The interior of the triphosphate-binding tunnel ( Fig. 2d and Supplementary Fig. 5 ) is accessible to solvent at the guanosine and α -phosphate and narrows at the β -and γ -phosphates, thereby excluding solvent. The oxygens on the 5′ -triphosphate form multiple direct hydrogen bonds (to all three phosphates) and indirect hydrogen bonds (to α -phosphate) from residues on helices α 7, α 6′ , α 5′ , and α 0, and adjoining loops (Fig. 3a-e and Supplementary Table 2 ) that form the tunnel. Additional hydrogen bonds from α 6′ and α 7 recognize the attached G1 base and ribose, respectively (Fig. 3e and Supplementary Table 2 ). These hydrogen bonds fix the otherwise highly flexible 5′ -triphosphate, thereby positioning the γ -phosphate oxygen for methyl transfer.
The terminal 2 bp and the following four ssRNA nucleotides (A109-U112) of SL1p are sequence-specifically recognized by MePCE MT , and G113 and C114 form backbone and ribose interactions to MePCE MT (Fig. 3a) . MePCE MT interacts in the major groove at the first 2 bp, forming hydrogen bonds to G1 and G2, as well as the phosphates (Fig. 3e-h ). Phe674 (α 7) stacks between the G1 ribose and the Arg425 (α 0) guanidinium plane, which then stacks on Arg433 (α 1), thereby encompassing the 'right wall' of the triphosphate-binding tunnel (Figs. 2e and 3e,g ). The terminal G1-C108 base pair and ssRNA nucleotides A109 and U110 straddle helix α 0, which is enriched in tyrosines whose aromatic rings splay out around α 0 (Fig. 3f ). This 'tyrosine wheel' forms intricate interactions with ssRNA nucleotides outside the active site, the 5′ -triphosphate within the active site, and helix α 7 residues (Fig. 3a-c,f ,g,i-k). Specifically, Tyr424 has π -π stacking and hydrogen-bonding interactions with the A109 base and ribose (Fig. 3f,i) .
C108, A109, and U110 have continuous base stacking (Fig. 3f,j) . The Lys420 side chain on the tyrosine wheel stacks between U110 and G111 and forms hydrogen bonds to U110 (Fig. 3f ,j,k). G111 forms a hydrogen bond to Ser482 (α 3) (Fig. 3k ) and stacks on G113 (Fig. 3f) , with the U112 base flipped 120° out about the G111 ribose. The U112 base forms stacking and hydrogen-bonding interactions with Fig. 1a . The methyl carbon is cyan. meSL1p and SAH are shown in ball-and-stick representation, and MePCE MT is shown as a cartoon. Inset, cube representation of the active site topology, defined by helix α 0 at the floor, helix α 5′ to the left, helix α 6′ at the ceiling, the β -sheet edge at the back, helix α 7 to the right, and SL1p at the front, as seen from the back wall. c, Crystal structure of MePCE-SAH (PDB 5UNA). d, The triphosphate-binding tunnel formed by helix α 0 and α 7 (blue) and helix α 5′ and α 6′ (green) in the MePCE-SAH-7SK structure. Protein residues are shown in transparent surface representation. RNA residue G1 and SAH are shown in ball-and-stick representation. e,f, MePCE MT N-and C-terminal loops in the presence (e) of SL1p are structured and form α 0 and α 7 helices (blue), but in the absence (f) of SL1p are disordered (represented as dashed blue lines). g,h, Surface representations of MePCE-SAH-7SK. In g, SAH is buried by MePCE MT N-and C-terminal regions and SL1p. In h, removal of SL1p RNA visually reveals the sulfur atom of SAH at the base of the triphosphate-binding tunnel. i, SAH is solvent accessible in the absence of bound RNA for MePCE-SAH (PDB 5UNA).
four residues from α 2 and α 3 (Fig. 3l) . U112 is the last RNA residue that is base-specifically recognized by MePCE MT ; G113 and C114 form only backbone interactions with helix α 3 residues (Fig. 3m) . The residues that participate in triphosphate and base-pair recognition are highly conserved in eukaryotes, whereas helix α 3 is highly conserved among vertebrates but poorly conserved in fission yeast and plants ( Supplementary Fig. 7 ). The large MePCE-RNA interaction surface explains the in vivo mutagenesis data indicating that a 5′ -hairpin structure followed by ssRNA nucleotides is required for the mpppG cap 7, 24 .
The cofactor and triphosphate are in a near-transition state. The positions of SAH in MePCE-SAH-7SK and MePCE-SAH-me7SK are nearly identical, and there are only minor rotations of the γ -and β -phosphates and shifting of the SAH sulfur ( Table 2 ). The SAH homocysteine amide forms a hydrogen bond to the Gly451 (β 1-α 2 loop, motif I) and Leu581 (β 4, motif II) backbone carbonyl groups, and the SAH carboxylate group forms three hydrogen bonds with the Arg433 guanidinium (α 1) and Tyr422 hydroxyl (α 0) (Fig. 4e and Supplementary  Table 2 ). Notably, in RNA-free MePCE− SAH, Tyr422 and Arg433 are partially disordered ( Supplementary Fig. 8 ). In contrast, they are highly ordered in the RNA-bound structures ( Supplementary  Fig. 5 ), thus indicating that RNA binding to MePCE MT further stabilizes SAH in its binding cleft.
In MePCE-SAH-me7SK, the methyl carbon has been transferred from SAM to the G1 γ -phosphate oxygen (Figs. 1b and 4g and Supplementary Fig. 4 ) with an O-C bond distance of 1.40 Å ( Supplementary Fig. 4 ). Superposition of the MePCE-SAH-7SK and MePCE-SAH-me7SK reveals a local shift in the SAH sulfur by 0.89 Å, which would allow room for the methyl group (Fig. 4b) . For MePCE-SAH-7SK, the distance between the SAH sulfur and G1 γ -phosphate oxygen (3.37 Å) equals the sum of their van der Waals (vdW) radii (3.32 Å) (Fig. 4f) (http://www.rsc.org/periodictable/), whereas for MePCE-SAH-me7SK, the distance between the , and G1 nucleotide (e). P i denotes phosphate. f, The tyrosine wheel in helix α 0 and the adjacent loop recognizes the helix-ssRNA junction of SL1p. Surface, stick, and cartoon representation are shown for the tyrosine residues and Lys420, and RNA residues are shown in ball-and-stick representation. g, Active site residues that participate in specific stacking and hydrogen-bonding interactions that stabilize helices α 0 and α 7. h, Protein residues that interact with the G2 nucleotide and backbone. i-m, Interactions between MePCE MT and the ssRNA nucleotides A109 (i); U110 (j); G111 (k); U112 (l); and G113 and C114 (m).
SAH sulfur and the G1 γ -phosphate O-methyl carbon (3.22 Å) is slightly smaller than the sum of the vdW radii (3.50 Å) (Fig. 4g) . These distances and geometries show a remarkable resemblance to a transition state, in which the methyl group would be located at an intermediate distance between the sulfur and γ -phosphate for in-line transfer. This proximity of reacting atoms at the active site is achieved by both the bidentate cofactor-binding cleft (Fig. 4a) , which fixes the sulfur atom in place, and the triphosphate-binding tunnel (Fig. 4c) , through which the γ -phosphate is anchored and positioned toward the cofactor sulfur atom. Although we do not have structural information for the starting state of the methyl-transfer reaction (SAM and uncapped RNA), the near-transition-state geometry of both the MePCE-SAH-7SK and MePCE-SAH-me7SK structures suggests that a similar geometry would be present in a MePCE-SAM-7SK complex, as modeled in Fig. 4h . Thus, we infer the methyl-transfer reaction mechanism to be the following: SAM cofactor first binds MePCE MT , and subsequent RNA binding further stabilizes and sequesters SAM in its binding cleft. The negatively charged G1 γ -phosphate oxygen is positioned in close proximity to the SAM methyl group, thus promoting nucleophilic attack at the positively charged methyl sulfonium moiety (Figs. 1a,b and 4h) . Notably, the γ -phosphate oxygens are fully deprotonated and negatively charged at neutral pH 26 , unlike protonated RNA substrates such as 2′ -OH or N2H 2 , and the SAM positively charged methyl sulfonium group is less stable than the neutral SAH sulfur, thus making the MePCE methyl-transfer reaction extremely electrostatically favorable and limiting the reverse reaction. After transfer of the methyl group to the G1 γ -phosphate oxygen, both the SAH byproduct and capped-RNA product remain bound in the active site (Figs. 2b and 4b,g ), which is facilitated by the extensive protein-RNA interactions discussed above.
To investigate the functional importance of interactions in the triphosphate-binding tunnel, we made individual alanine substitutions at three highly conserved residues ranging from the closest to the methyl-transfer reaction to the solvent-exposed G1 ribose-Y421A (α 0), K585A (α 5′ ), and F674A (α 7) (Fig. 4c) -and compared their methyltransferase activity to that of wild-type MePCE MT within a single turnover (Fig. 4i) . Tyr421, located at the floor of the triphosphate-binding tunnel (Fig. 2b,d) , forms a hydrogen bond to and buttresses the γ -phosphate (Fig. 3a,b,f) and is the closest side chain to the methyl group before transfer (Fig. 4h) . Y421A was found to be nearly catalytically dead (0.6% activity) (Fig. 4i) , thus indicating the critical importance of Tyr421 for formation of the active site and stabilization of the γ -phosphate. Alanine substitution of Lys585, which has hydrogen bonds to the γ -and β -phosphate oxygens (Fig. 3a-e) , decreased activity to 32% (Fig. 4i) , thus indicating that Lys585 has a major role within the MePCE MT -triphosphate-recognition network. Partial activity is likely to be maintained by the remaining 9 of 11 direct hydrogen bonds to the triphosphate and the retention of most of the left side (helix α 5′ ) of the tunnel. Alanine substitution of Phe674, which would expose the right side (helix α 7) and destabilize the ceiling of the tunnel by disrupting the stacking interactions with Arg425 and G1 ribose, decreased activity to 2.5% (Fig. 4i) . These results verify the structural and functional importance of the triphosphate-binding-tunnel residues and highlight the importance of residues in the regions that become ordered upon RNA binding.
MePCE binds tightly to capped RNA. Under single-turnover conditions, SL1p was fully monomethylated in less than 15 min ( Fig. 1d and Supplementary Fig. 3 ). In time-dependent activity assays at different SL1p concentrations, we similarly observed quantitative methylation under single-turnover conditions (MePCE MT in molar excess to RNA); however, nonlinear behavior was observed under multiple-turnover conditions (Fig. 5a ). These data reflect an initial fast phase corresponding to a quantitative single turnover, followed by a slow phase corresponding to a second turnover event that is limited by product release 27 .
To explain these results, we first investigated the equilibrium dissociation constants (K d ) of the cofactor SAM and the byproduct SAH to MePCE MT by using isothermal titration calorimetry (ITC) (Supplementary Fig. 9a,b) . MePCE MT bound SAM with 13-fold lower affinity than that to SAH, thus suggesting that SAH may be a product inhibitor to MePCE, as seen in some SAM-dependent Rossman-fold MTases [28] [29] [30] [31] [32] . Using ITC, we next investigated the binding of MePCE MT to various RNA substrates including SL1pΔ ss (no ssRNA), SL1pΔ 1-3 (no internal loop), and three pairs of unmethylated and methylated constructs: SL1p (Fig. 5b,c) , S1alt from the proposed 5′ stem of the alternative circular 7SK model, and SL1 of the U6 small nuclear RNA (U6-SL1 and meU6-SL1), the only other predicted substrate of MePCE in humans (Fig. 5d, Supplementary Fig. 9 , Table 1 and  Supplementary Table 3 ). To ensure that only binding energies were measured, we performed the experiments in the presence of SAH rather than SAM. SL1pΔ ss had no detectable binding by ITC (K d » 1 μ M), thus indicating that the 3′ ssRNA overhang is required for high-affinity binding. In contrast, no difference in binding affinity was observed between SL1p and SL1pΔ 1-3, a finding consistent with the lack of interactions observed between MePCE MT and the internal asymmetric loop in the crystal structures. U6-SL1 had a fourfold-higher binding affinity than 7SK SL1p to MePCE MT (Table 1, Supplementary Table 3 and Supplementary  Fig. 9 ). Like SL1p, U6-SL1 has a terminal G-C base pair, and although the penultimate base pair is a U-A instead of a G-C, equivalent hydrogen bonds could be made between protein and base. The first 6 nt of the 3′ ssRNA sequence are alternating purine and pyrimidine nucleotides (AUAUACU), as compared with AUGUGCG in 7SK SL1p (Fig. 5d) . In U6, the two A nucleotides are expected to stack similarly to SL1p G111 and G113 (ref. 33 ), and the top A nucleotide, like SL1p G111, could accommodate a hydrogen bond to Ser482 (Fig. 3f,k) . In contrast, the binding affinity of MePCE MT to S1alt was eightfold lower than that to SL1p. S1alt and SL1p both have two G-C base pairs, but in S1alt, the 3′ ssRNA region is not alternating purine-pyrimidine and is 3 nt shorter (AAAUG) (Fig. 5d) . Given that SL1p bound MePCE MT with higher affinity and that MePCE is likely to associate with 7SK as it is being transcribed before the 5′ end and the region near the 3′ end can base-pair 9 , these data suggest that the linear 7SK model is the substrate for MePCE, in agreement with biochemical experiments 8 . MePCE MT bound to meSL1p with approximately twofold-higher affinity than to SL1p (Δ Δ G cap 0.6 ± 0.3 kcal/mol (mean ± s.d.)) ( Table 1, Supplementary Table 3 and Supplementary Fig. 9 ). The unexpected finding that the product bound with higher affinity than the substrate explains how 7SK is retained by MePCE after capping. MePCE bound to S1alt almost an order of magnitude more weakly than to SL1p, but bound meS1alt with an affinity comparable to that toward uncapped SL1p, with an approximately fivefold higher affinity for meS1alt than S1alt (Δ Δ G cap 1.0 ± 0.2 kcal/mol). These results do not exclude an assembly model in which MePCE binds circular 7SK after capping of linear 7SK.
Although MePCE MT bound tightly to both capped and uncapped U6-SL1 (Δ Δ G cap 0.0 ± 0.2 kcal/mol) with comparable affinity, the affinity was approximately the same as for meSL1p, thus suggesting that MePCE remained bound to U6 small nuclear RNA after capping, in agreement with MePCE pulldown assays 6, 7 . Catalytic turnover is inhibited by product and byproduct binding. The above results indicate that both capped RNA and SAH byproduct can act as inhibitors. To validate the proposed product-inhibition mechanism, we performed methyltransferase activity assays to determine whether binding affinities might be correlated with turnover ( Fig. 5e and Supplementary Fig. 10 ). As discussed above, MePCE MT exhibited fast kinetics within one turnover and a slow phase for the subsequent turnovers, which is likely to be limited by product release (Fig. 5a ). As expected, addition of Mg 2+ to the methyltransferase assay had no statistically significant effect on activity. Under multiple turnover conditions, S1alt had 19% higher apparent activity than SL1p. Because meS1alt had lower binding affinity than meSL1p, these results suggest that meS1alt has weaker product inhibition, thus allowing MePCE MT to proceed to multiple turnovers. In contrast, the apparent activity on U6-SL1 was 36% less than that on SL1p. We note that under multiple turnover conditions with U6-SL1, one stoichiometric methylation was completed at approximately 15 min, thus indicating that the decreased activity with U6-SL1 is due not to an abortive methyl-transfer reaction but instead to a decreased rate of product release, in agreement with the higher binding affinity of MePCE for meU6-SL1 than meSL1p (Supplementary Table 3 ). SL1pΔ ss had no detectable binding to MePCE MT by ITC but was capped, although with 39% lower activity. This moderately decreased activity probably reflects both weaker protein-RNA binding and drastically decreased product inhibition. As further support for the product-inhibition model, we doped the MTase assays with SAH or meSL1p, which decreased activity by 23% and 34%, respectively.
In summary, the enzymatic activity of MePCE is an extreme case of product inhibition wherein both the byproduct and product have higher affinity toward the MTase domain than that of the corresponding cofactor and RNA substrate. The retention of a monomethylated RNA product also explains why MePCE methylates only a single γ -phosphate oxygen. Together, the structural, binding, and enzymatic data demonstrate that MePCE generally functions as a single-turnover enzyme and explain the dual role of MePCE in 7SK RNP biogenesis in capping the 5′ γ -phosphate to protect RNA from degradation and as a constitutive component of the 7SK core RNP.
Comparison to other MTases highlights unique features of
MePCE. We compared substrate-and cofactor-binding sites of MePCE to those in structures of two other RNA-capping MTases bound to substrate: VP39 (PDB 1AV6), a well-studied mRNA ribose O2′ -cap1 MTase, and Tgs1, an mRNA TMG-capping MTase (PDB 3GDH) ( Supplementary Fig. 11 ). In contrast to the large RNA-binding surface on MePCE, VP39 and Tgs1 have base-specific contacts to only two or one nucleotides, respectively. MePCE has a large positively charged surface area and buried active site with an enclosed cofactor, whereas VP39 and Tgs1 have much smaller positively charged surface areas and relatively shallow active sites with solvent-accessible cofactor. In the MePCE active site, methyl-donor and methyl-acceptor atoms are within vdW radius (Fig. 4f,g and Supplementary Fig. 11g ). The donor and acceptor atoms in VP39 and Tgs1 are farther apart, probably because both the ribose 2′ -OH group (VP39) and the N2 amino group (Tgs1) require a deprotonation step before methyl transfer ( Supplementary Fig. 11h,i) . BCDIN3D 34, 35 , a recently discovered MePCE paralog that methylates the 5′ -α -phosphate of tRNA His and pre-microRNA, has substantial sequence homology to MePCE, including helix α 0 tyrosine-wheel residues and residues involved in 5′ -end and cofactor recognition (Supplementary Fig. 7) , thus suggesting that it may recognize its 5′ -hairpin-single-stranded substrates in a similar way to MePCE. In contrast, the MTase METTL16, which also modifies 7SK and U6, lacks helix α 0 and conserved residues involved in 5′ -end recognition by MePCE, in agreement with its internal N 6 -methyladenosine-modification function 36, 37 . This comparison of RNA-capping MTases highlights the unique features of MePCE: a large substrate-recognition surface; enclosed active site; and substrate and cofactor poised in near-transition-state geometry. The parameters determined from n fits were averaged to determine the mean and s.d., where n is as follows: SAM (n = 2); SAH (n = 4); SL1p (n = 6); meSL1p (n = 3); S1alt (n = 2); meS1alt (n = 3); SL1pΔ ss (n = 2); SL1pΔ 1-3 (n = 4); U6-SL1 (n = 4); meU6-SL1 (n = 2) Discussion RNA 5′ caps are required for RNA biogenesis, stability, splicing, cellular localization, and protein interactions 1,2 . However, the molecular mechanisms of the MTases responsible for capping have not been well characterized, primarily because of a lack of structural information on substrate recognition. The MePCE-SAHme7SK crystal structure is, to our knowledge the first reported structure of an RNA MTase in complex with its capped RNA product at the active site. This structure, together with the MePCE-SAH-7SK crystal structure, reveals a reaction mechanism in which the reactants and products remain in a near-transition-state geometry in the active site for the entire reaction process. Comparison to the substrate-free MePCE-SAH structure shows a disorder-toorder conformational change for the N-and C-terminal regions after binding RNA, thus encapsulating and blocking diffusional exit of the cofactor and positioning the substrate for reaction. The structures also reveal atomic details of an extensive interaction network that recognizes 5′ -triphosphate and base-paired and single-stranded nucleotides through both unique and canonical Rossman-fold methyltransferase α -helices. Notably, the binding affinity of capped 7SK SL1p to MePCE MT with SAH is higher than that of the uncapped RNA. The higher affinity of products over reactants to MePCE explains how MePCE becomes a stable component of the 7SK RNP after catalysis. The structural and mechanistic comparisons of MePCE to other RNA MTases described above further explain why MePCE is inhibited by both product and byproduct, and how it retains product in the active site. Although there are apparently some protein MTases that retain their products (for example, protein l-isoaspartyl methyltransferase 30 and protein arginine methyltransferase 3 (PRMT3), through its N-terminal zinc-finger domain 38 ), MePCE is the only known RNA MTase that retains product after catalysis.
MePCE concentrates at the 7SK and U6 promoter regions 9 , and 5′ capping is likely to occur cotranscriptionally after the specific helix-ssRNA region is transcribed. Our binding analysis and activity assays indicate that U6-SL1 interacts with MePCE with higher affinity than does 7SK and is capped by MePCE in a similar product-inhibited manner. These observations validate U6 as a MePCE substrate and explain the association of MePCE with U6 in vivo (through pulldown assays), at least before formation of the U4/U5/U6 tri-small nuclear RNP 6, 7, 39 . Given that an RNA construct corresponding to the 5′ end in the circular 7SK model bound MePCE MT with approximately eightfold lower affinity than a construct corresponding to the linear 7SK model, and in vivo the circular 7SK model cannot form until transcription of full-length 7SK is nearly complete, we propose that the linear 7SK model is the substrate for MePCE capping. Larp7, which has strand melting and annealing properties 40 common to LARPs and La protein 41, 42 , may subsequently remodel 7SK upon assembly, thereby altering the MePCE-RNA interface and promoting the stable association between MePCE and Larp7. The retention of MePCE on 7SK as a core component of the 7SK RNP highlights the unique nature of 7SK: it is capped at the 5′ end by a specialized MTase that remains bound after catalysis, and the same MTase is then joined with a 3′ -end-associating La-related protein, thus forming a stable ternary RNP. This work provides a structural and mechanistic basis for the role of MePCE in the first steps of 7SK RNP assembly.
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In vitro transcription of RNA. RNA samples were prepared by in vitro transcription as described previously 22 with chemically synthesized DNA templates (Integrated DNA Technologies). Briefly, the transcription reaction was incubated for 4-6 h at 37 °C and was followed by purification by 15-20% denaturing PAGE, excision of RNA and elution with an Elutrap device (GE Waters). Collected RNA eluents were buffer exchanged into sterilized nanopure water supplied with counterions by the addition of high-salt buffer (1.5 M KCl), and briefly buffer exchanged into nanopure water before being annealed by heating to 95 °C for 5 min and snap cooling on ice for 1 h. RNAs were then desalted into sterilized nanopure water or buffer C/B and concentrated with Amicon ultracentrifugal filters (3-kDa MWCO, Millipore). Stock solutions of RNA were stored in a -20 °C freezer.
Methylated-RNA sample preparation. MePCE MT , RNA, and SAM were mixed in molar ratios of 1:1:3 or 0.5:1:3 and incubated at 37 °C for > 24 h in buffer B. RNA was purified by phenol-chloroform extraction followed by ethanol precipitation and buffer exchanged into nanopure water. Sample homogeneity was verified by mass spectrometry (Supplementary Figs. 3 and 12-14) .
Crystallization and data collection. All crystallization trials were performed with the hanging-drop vapor-diffusion method at 4 °C with MePCE MT in complex with 7SK SL1p RNA and SAM or SAH at a concentration of 8-10 mg/mL. The molar ratio of cofactor-bound MePCE MT and SL1p RNA was determined with electrophoretic mobility shift assays, in which the RNA reached stoichiometric saturation with protein. In our hands, the SL1p RNA was saturated by a 1.5-fold molar access of MePCE MT in the presence of SAM or SAH. For assembly of the MePCE MTase− SL1p complex, a dilute protein solution from the SEC elution in buffer C with added SAM or SAH was combined with RNA in buffer C and concentrated with 3-kDa MWCO Amicon ultracentrifugal filters (Millipore) at 4 °C. The final molar concentration of MePCE MT (ε = 51,715 l mol −1 cm −1 at A 280 ) was 0.19-0.24 mM, and that of SL1p RNA (ε = 317,600 l mol −1 cm −1 at A 260 ) was 0.13-0.16 mM.
Before crystallization, the protein-RNA solutions were mixed with the wellsolution buffers at a 2:1 (vol/vol) ratio. For the MePCE-SAH− 7SK structure, single crystals grew in approximately 1 week with a well solution of 0.1 M phosphate/ citrate, pH 4.2, 0.214 M lithium sulfate and 17.25% (wt/vol) PEG 1000. The crystals were transferred in a cryoprotectant containing 50% glycerol and flash frozen in liquid nitrogen. The structure was solved by molecular replacement with Phaser 43 with the MePCE− SAH structure (PDB 5UNA, chain E) as a search model. RNA density for the 5′ -triphosphate and the first three bases was apparent in the electron density map. RNA was built into the electron density with Coot 44 and iteratively refined to 2.0-Å resolution with Phenix 45 . For the MePCE-SAH− me7SK structure, the sample was prepared as described above with SAM instead of SAH. Single crystals grew in approximately 1 week and continued to grow over 2 months in a well solution of 0.1 M phosphate/ citrate, pH 4.2, 0.2 M lithium sulfate, and 25% (wt/vol) PEG 1000. The crystals were transferred to an undiluted drop of well solution supplemented with 1.2 mM MgCl 2 , soaked for 2 h and flash frozen in liquid nitrogen. The structure was solved by molecular replacement with Phaser with the refined MePCE-SAH− 7SK model. The additional methyl group on the γ -phosphate was apparent from both 2F o -F c and F o -F c maps ( Supplementary Fig. 4 ). The γ -phosphate monomethylated GTP geometry was built with phenix.elbow 46 , and the final structure was refined to 2.1-Å resolution with Phenix. Independent soaking experiments were also performed with both MePCE-SAH− me7SK and MePCE-SAH− 7SK crystals in the following conditions: 1.2 mM MgCl 2 , 1.2 mM SmCl 3 , 2.4 mM MgCl 2 , and 2.4 mM SmCl 3 . Two soaking times-overnight or 2 h-were used for all conditions. MePCE-SAH− me7SK crystal from the 2-h, 1.2 mM MgCl 2 condition was used for final refinement and deposition.
All data were collected on beamline 24-ID-C (NE-CAT) at the Advanced Photon Source at Argonne National Laboratory (APS-ANL, Argonne, IL, USA) at a wavelength of 0.9792 Å and temperature of 100 K, with a Dectris Pilatus 6 M detector. Data were indexed and integrated with XDS and scaled with XSCALE 47 . Final iterative rounds of model building and refinement were performed with Coot and Phenix with TLS refinement 48 . Composite refine omit maps 49 were generated with Phenix, and PyMOL 2.0.6 was used to generate structural figures. Crystallization data collection and refinement statistics are presented in Supplementary Table 1 . The electrostatic potential of the MePCE-SAH-7SK, VP39, and Tgs1 structures was calculated with Adaptive Poisson-Boltzmann Solver (APBS) through the PDB2PQR 50 and APBS 51 webservers.
NMR spectroscopy. Capped RNA samples for 13 C NMR experiments were generated by incubating freshly purified MePCE MT , S-methyl- 13 C SAM (99 atom % 13 C; Sigma Aldrich/ISOTEC), and RNA samples in a molar ratio of 1:3:1 in buffer C at 37 °C for 1 h. The reactions were quenched, and RNA was separated by phenol-chloroform extraction. The RNA samples were further purified by ethanol precipitation, air dried, and dissolved in NMR buffer. The uncapped and capped RNA NMR samples contained 50-100 μ M RNA, in a buffer of 10 mM sodium phosphate, pH 6.2, 60 mM KCl, 5% (vol/vol) D 2 O, and 0.6 mM NaN 3 . All NMR spectra were collected at 15 °C with Bruker DRX 500 MHz and Avance 800 MHz spectrometers equipped with cryogenically cooled probes. Data were collected with TopSpin (Bruker), processed with NMRPipe 52 , and analyzed in NMRFAM-Sparky 53 . 1D 1 H flipback NMR spectra 54 were used to quantify (S,S) and (R,S) diastereomers of SAM. SAM salts were dissolved in the RNA NMR buffer. The peaks at 3.01 p.p.m. and 2.97 p.p.m. were assigned to methyl protons from (S,S) and (R,S) diastereomers, respectively, on the basis of the decrease in relative intensity of the (S,S) peak after a 7-d incubation and previously reported chemical-shift values 55 . SAM p-toluenesulfonate salt and SAM iodide salt (Sigma A4377) were found to contain 76.63% and 73.79% (S,S) diastereomer, respectively. All SAM concentrations in the methyltransferase and ITC experiments refer to the total concentration of SAM, on the basis of the A 260 . However, the SAM concentrations were adjusted to the active (S,S) diastereomer in calculation of molar methyl transfer.
Mass spectrometry analysis of RNA and purified MePCE MT protein. The uncapped and capped RNA samples were desalted with ammonium acetate precipitation to replace the Na + on the RNA backbone 56 . The desalted RNA samples were dissolved in ultrapure water to 20 μ M and analyzed with the direct infusion method on a Q Exactive Plus Orbitrap mass spectrometer (Thermo Fisher Scientific) in negative mode with 70,000 resolving power at 200 m/z. 100 scans were acquired to improve the signal-to-noise ratio.
SAM/SAH standard mixture and freshly purified MePCE MT protein were analyzed on a ZORBAX C3 column, 3.0 × 150 mm, with bead size 3.5 μ m (Agilent Technologies) with Agilent 6530 Q-TOF ESI with a 1260 Infinity LC. Buffers A and B were 0.1% formic acid in water and 0.1% formic acid in acetonitrile, respectively. A linear gradient from 1% to 99% B was applied for 8 min, and eluates were analyzed with an ESI-TOF mass spectrometer in positive mode.
Methyltransferase assay. In vitro RNA methyltransferase assays were adapted from established protocols 57, 58 . All experiments were performed in a reaction buffer of 50 mM HEPES, pH 7.5, 150 mM KCl, and 1 mM TCEP at 37 °C with 1 μ M MePCE MT and 20 μ M SAM. SAM is a mixture of 20:1 molar ratio of S-(5′ -adenosyl)-l-methionine p-toluenesulfonate salt (SAM) (Sigma A2408; ≥ 80% purity) to S-(5′ -adenosyl)-l-[methyl- Reactions were quenched by prompt heating to 98 °C and were maintained for 2 min in a preheated thermocycler at different time points. 25 μ L of the 30 μ L reaction mixtures was spotted on Amersham Hybond-N + membrane (GE Healthcare), air dried for 30 min, washed twice with 100 mL of 50 mM NaHCO 3 , pH 9, for 45 min and air dried for 90 min. The membranes were placed in vials and soaked with 5 mL of Safety-Solve scintillation solution (Research Products International 111177) overnight and counted for three cycles of 5 min with a Beckman scintillation counter. Product-RNA concentration was quantified by conversion of c.p.m. counts to molar concentrations with 58% counting efficiency for the scintillation counter, SAM-to-[me 3 H]SAM molar ratio, and (S,S) diastereomer purity of 76.63%, as determined from NMR.
The progress curves with varying RNA concentrations were fit to a two-step kinetics equation as follows: n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested All studies must disclose on these points even when the disclosure is negative.
Sample size
A sample size of three independent experiments are chosen for comparing all relative enzymatic activities. Two to six independent experiments with good agreement within each group are performed for binding experiments. No sample size calculation was performed. The sample sizes were chosen by commonly used sizes for these type of experiments.
Data exclusions No data were excluded from the analyses.
Replication
All replicates were performed in independent measurements and were successful. Additional control kinetic and ITC experiments with wildtype protein and RNA from three or more batches of protein purified show good reproducibility.
Randomization The order of protein substitutes used is randomized and shows no correlation between order of usage and resulting relative activities.
Blinding
Not applicable to the study as all biochemical reagents are clearly labeled.
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